Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient.
Montiel
Pilar Martinez
PM
Solis
Jose Antonio
JA
Chirinos
Juan Antonio
JA
a Casis
Begoń
B
Sánchez
Fernando
F
Rodríguez
Sarbelio
S
D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy; D000068800:Etanercept; D006509:Hepatitis B / Q000097:blood / Q000139:chemically induced* / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000097:blood; D006511:Hepatitis B Antigens / Q000097:blood; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D012008:Recurrence
D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept